LENZ Therapeutics, Inc.
LENZ · NASDAQ
Bulios Fair Price
$4.51
19.0% upside
Current Price
$3.79
According to Bulios Fair Price, LENZ is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
LENZ Therapeutics (LENZ) is a biotechnology company based in the United States, focused on developing new therapeutic treatments for neurological disorders, particularly epilepsy and other central nervous system disorders. The company specializes in discovering and developing innovative drugs aimed at improving the lives of patients suffering from these serious diseases. LENZ Therapeutics utilizes advanced technologies and scientific insights to discover new therapeutic possibilities and focuses on the efficacy and safety of its products. LENZ Therapeutics (LENZ) shares could be suitable for investors looking to invest in the biotechnology sector with potential for innovations in the treatment of neurological disorders.
Sector
Healthcare
Industry
Biotechnology
CEO
Evert Schimmelpennink
Employees
152
Headquarters
Solana Beach
Upcoming events
Earnings
Upcoming earnings report